Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P0DM35
UPID:
M1BL1_HUMAN
Alternative names:
-
Alternative UPACC:
P0DM35
Background:
Metallothionein 1H-like protein 1 is characterized by its high cysteine content, enabling it to bind various heavy metals. This binding capability is crucial for detoxifying heavy metals and protecting cells from metal toxicity. The expression of this protein is intricately regulated by both heavy metals and glucocorticoids, highlighting its significance in cellular response to environmental and hormonal changes.
Therapeutic significance:
Understanding the role of Metallothionein 1H-like protein 1 could open doors to potential therapeutic strategies. Its ability to bind heavy metals suggests a pivotal role in detoxification processes, which could be harnessed in treatments for heavy metal poisoning or disorders related to metal homeostasis.